Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Marinos Dalakas MD, FAAN
Marinos C. Dalakas MD, FAAN Advisory Board
Mark Hallett MD
Mark Hallett MD Editor-in-Chief
Argye Hillis MD, MA
Argye Elizabeth Hillis MD, MA Associate Editor
See All Experts
Published in Neurology

News · July 10, 2024

EAN 2024: Nipocalimab Improves Disease Control in Myasthenia Gravis

Scores improved for activities of daily living with nipocalimab compared with placebo

PracticeUpdate Editorial Team

 

 Save  Recommend
 Share

Further Reading

Most Read This Week

Recently Updated